JAZZ · NASDAQ · STOCK
Jazz Pharmaceuticals (JAZZ) Stock Analysis
$246.94
52W $123.88 – $266.38
60/100
$15.50B
16.2
0.32
Is JAZZ Bullish or Bearish?
Bullish.
Innellis AI committee rates Jazz Pharmaceuticals (JAZZ) Buy with a composite score of 60/100
, based on 5 analysts with 60% agreement.
Last updated September 06, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +15.17 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -4.83 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
Positive signals support the current rating — vix regime is low -- calm backdrop supports risk-taking. The committee sees sufficient evidence to maintain the constructive view.
Bull & Bear Case
Bull Case
- ROE of 21.4% shows genuine earnings power backing the valuation — Value
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- MACD histogram negative -- bearish momentum — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of September 06, 2026
Overall Committee Score
60/100
Agreement
60%
Analysts
5
Conviction
Moderate
Sector Rank
Top 54%
of 192 Healthcare peers
Value Analyst
bullish
63
/ 100 · Moderate confidence
Classic value case: cheap on multiples with earnings power to back it up
+ ROE of 21.4% shows genuine earnings power backing the valuation
Growth Analyst
neutral
50
/ 100 · Moderate confidence
Moderate growth -- present but not remarkable
− Growth rate is decelerating quarter over quarter -- the trend line matters more than the level
Technical Analyst
neutral
48
/ 100 · High confidence
Mixed or range-bound price action
− MACD histogram negative -- bearish momentum
Macro Analyst
bullish
80
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst
neutral
58
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2704.43)
Investment Thesis Evolution
Committee score moved marginally from 59.8 to 59.8.
Comparing 2026-09-05 to 2026-09-06 (1 day apart).
Technical Analysis
RSI (14)
45.7
Neutral
MACD Histogram
-0.909
Bearish Momentum
Trend Direction
Sideways
Weekly: Uptrend
Market Structure
Hh Hl
Bollinger %B
0.34
Inside Bands
Price vs Moving Averages
EMA 9
$248.13
Below
EMA 21
$249.46
Below
EMA 50
$246.03
Above
EMA 200
$209.61
Above
Fundamental Analysis
Valuation
89
Growth
59
Profitability
50
Financial Health
80
Cash Flow
70
Valuation
P/E Ratio
16.2×
P/B Ratio
3.25×
PEG Ratio
0.00
Dividend Yield
0.00%
52W High
$266.38
52W Low
$123.88
Quality & Growth
ROE
-824.7%
ROA
-305.5%
Gross Margin
8467.4%
Operating Margin
3105.1%
Revenue Growth YoY
—
Debt / Equity
0.92
AI Fundamental Assessment
P/E ratio of 16.2 (inexpensive relative to a 15-40x range); Price-to-book of 3.2x; PEG ratio of 0.0 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -8.2%; Return on assets of -3.1%; Net margin of 20.4%; Gross margin of 84.7%; Current ratio of 1.78 (healthy short-term liquidity); Debt-to-equity of 0.92; Free cash flow per share is positive (24.40); Most recent quarter missed estimates by 9.4%; EPS growth decelerating (-4.5% -> -9.9% QoQ); Average YoY EPS growth of 169.2%; Analyst estimates falling over recent quarters
Get the Full JAZZ Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →